Clinical Trials List
2023-11-15 - 2031-12-31
Phase III
Not yet recruiting9
Recruiting2
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Shang-Yin Wu 無
- Chian-Wei Chen 無
- Chun-Hui Lee 無
- Chin-Wei Kuo 無
- Wu-Chou Su 無
- 蔡政軒 無
- 林建佑 無
- Po-Lan Su 無
- Seu-Chun Yang 無
- Yu-Min Yeh 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Jen-Yu Hung 無
- 莊政皓 無
- 李玫萱 無
- 郭家佑 無
- Inn-Wen Chong 無
- Ying-Ming Tsai Tsai 無
- KUAN-LI WU 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jih-Hsiang Lee 無
- JIN-YUAN SHIH 無
- 陳冠宇 無
- 廖斌志 無
- CHAO-CHI HO CHAO-CHI HO 無
- 林宗哲 無
- 徐偉勛 無
- 黃得瑞 無
- 蔡子修 無
- 吳尚俊 無
- Chia-Chi Lin 無
- 許嘉林 無
- 廖唯昱 無
- Chong-Jen Yu 無
- YEN-TING LIN 無
- WEI-LI MA 無
- 楊景堯 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chia-Chi Lin 無
- YEN-TING LIN 無
- 廖斌志 無
- 林宗哲 無
- 黃得瑞 無
- 吳尚俊 無
- JIN-YUAN SHIH 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
35 participants
-
Global
556 participants
